DEVIN ERICSON: Open Payments
NPI 1245850619 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,168 in 58 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $452 · 2025 $1,168
Food & beverage: $1,168
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $225 |
| AstraZeneca Pharmaceuticals LP | 10 | $219 |
| Novo Nordisk Inc | 6 | $111 |
| Exact Sciences Corporation | 4 | $95 |
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| PFIZER INC. | 4 | $74 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Amgen Inc. | 3 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
Products named: MOUNJARO, AIRSUPRA, Cologuard Collection Kit, REXULTI, Wegovy, JARDIANCE, GVOKE HYPOPEN, PREVNAR 20.
Industry payments across MO — which companies pay providers there.
